Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Journal of Clinical Endocrinology & Metabolism (JCEM)
Published September 29, 2026
Metabolic status modifies skeletal response to active vitamin D: A post hoc analysis of the DPVD ...
September 30, 2026
Medspoke
Medspoke
The Lancet Diabetes & Endocrinology
Published September 29, 2026
00:00
--:--
Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, dou...
September 30, 2026
Share
Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial.
https://www.medspoke.co/channel_journal?id=680&tap_id=14740
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Journal of Clinical Endocrinology & Metabolism (JCEM)
Published September 30, 2026
Glycemic and psychosocial outcomes of automated insulin delivery in older and high-risk populatio...
September 30, 2026
Why are you reporting this TALK?
